Early assessment of MRD using a highly sensitive NGS assay identifies MRD positive cases (samples that were MRD negative by flow cytometry, 46% were MRD+ by the NGS) and adds clinically relevant prognostic information to FC-based approaches.
https://t.co/ZroQqrcPhr